Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03471663
Title A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors InventisBio Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.